<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00872001</url>
  </required_header>
  <id_info>
    <org_study_id>P05633</org_study_id>
    <secondary_id>MK-8395</secondary_id>
    <secondary_id>RED-CABG</secondary_id>
    <nct_id>NCT00872001</nct_id>
  </id_info>
  <brief_title>The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)</brief_title>
  <acronym>RED-CABG</acronym>
  <official_title>The Effect Of Acadesine On Clinically Significant Adverse Cardiovascular and Cerebrovascular Events In High-Risk Subjects Undergoing Coronary Artery Bypass Graft (CABG) Surgery Using Cardiopulmonary Bypass (Protocol No. P05633): RED-CABG Trial (Reduction in Cardiovascular Events by AcaDesine in Subjects Undergoing CABG)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Duke Clinical Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Merck Sharp &amp; Dohme Corp.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether acadesine is effective in reducing the
      cardiovascular and cerebrovascular adverse events in high-risk participants undergoing CABG
      surgery.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of All-cause Death, Non-fatal Stroke, and Need for Mechanical Support for Severe Left Ventricular Dysfunction (SLVD) (Intent-to-Treat Population)</measure>
    <time_frame>Up to Post-Operative Day 28</time_frame>
    <description>Incidence of all-cause death, non-fatal stroke, or need for mechanical support for SLVD (any component and composite) through post-operative Day 28 during and following CABG and administration of acadesine or placebo. Components defined as follows: All-cause death: Death from any cause, Non-fatal Stoke: occurrence of a stoke that was confirmed and adjudicated by Clinical Endpoints Committee that did not result in death, and Mechanical Support for SLVD: New use of any mechanical support for ≥1 hour for treatment of low cardiac output.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Cardiovascular Death, Non-fatal Stroke, and Need for Mechanical Support for SLVD (Intent-to-Treat Population)</measure>
    <time_frame>Up to Post-Operative Day 28</time_frame>
    <description>Incidence of cardiovascular death, non-fatal stroke, and need for mechanical support for SLVD (any component and composite) through post-operative Day 28 during and following CABG and administration of acadesine or placebo. Components defined as follows: Cardiovascular death: Death due to cardiovascular causes, Non-fatal Stroke: occurrence of a stroke that was confirmed and adjudicated by Clinical Endpoints Committee that did not result in death, and Mechanical Support for SLVD: New use of any mechanical support for ≥1 hour for treatment of low cardiac output.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">3080</enrollment>
  <condition>Coronary Artery Bypass</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Ventricular Dysfunction, Left</condition>
  <condition>Stroke</condition>
  <condition>Cardiopulmonary Bypass</condition>
  <arm_group>
    <arm_group_label>Acadesine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Acadesine intravenous (IV) infusion, plus cardioplegia solution with acadesine, and priming solution with acadesine in the heart lung machine during cardiopulmonary bypass (CPB)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline, IV infusion, plus cardioplegia solution with added normal saline, and priming solution with added normal saline in the heart lung machine during CPB</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acadesine</intervention_name>
    <description>Acadesine 42 mg/kg diluted in normal saline to a total of 500 mL, delivered as an IV infusion over approximately 7 hours commencing within approximately 30 minutes before induction of anesthesia at a rate of 0.1 mg/kg/min (translating into 1.2 mL/min for a 500 mL solution). In addition, a 5 µg/mL cardioplegia solution of acadesine will be administered, and acadesine will be added to the priming solution (5 µg/mL) in the heart lung machine during CPB.</description>
    <arm_group_label>Acadesine</arm_group_label>
    <other_name>SCH 900395</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal Saline</intervention_name>
    <description>Normal saline, 500 mL delivered as an IV infusion over approximately 7 hours commencing within approximately 30 minutes before induction of anesthesia at a rate of 1.2 mL/min for a 500 mL solution. In addition, standard cardioplegia solution with added normal saline will be administered, and placebo (normal saline) will also be added to the heart lung machine priming solution.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A high risk participant undergoing non emergency CABG surgery requiring CPB and
             cardioplegia.

          -  Age: &gt;=50 years

          -  At least one of the following risk factors:

               -  Female (but not pregnant or lactating), or

               -  History of prior CABG, or

               -  History of myocardial infarction (MI), or

               -  History of ischemic stroke, or

               -  Left ventricular ejection fraction &lt;=30%, or

               -  Diabetes mellitus requiring insulin and/or antidiabetic agents.

          -  Significant coronary artery stenosis

        Exclusion Criteria:

          -  Planned valve replacement, carotid artery or aortic surgery, distal coronary
             endarterectomy,surgical ablation for cardiac arrhythmia, or ventricular
             aneurysmectomy, alone or with CABG surgery (repair for mild to moderate mitral valve
             disease with concomitant CABG is not excluded).

          -  Planned or staged major surgery within 30 days of CABG surgery

          -  CABG surgery using intermittent aortic cross clamping without cardioplegia.

          -  Minimally invasive surgery (ie, without use of CPB).

          -  MI within 5 days prior to surgery.

          -  Pre-operative or planned intra operative/postoperative use of intra-aortic balloon
             pump (IABP), ventricular assist device (VAD), extra-corporeal membrane oxygenator
             (ECMO), or other mechanical hemodynamic assist device.

          -  History or presence of gout or uric acid nephrolithiasis.

          -  Serum creatinine &gt;2 mg/dL (180 µmol/L).

          -  Serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST) &gt;2 x Upper
             Limit of Normal (ULN).

          -  Adenosine, aminophylline, nicotinic acid, pentoxifylline, theophylline, and any
             cardioplegia solution containing adenosine, dipyridamole or lidoflazine within 24
             hours before surgery:

          -  Dipyridamole within 2 days and allopurinol or febuxostat within 4 days before surgery

          -  Food and drinks containing caffeine, theobromines or methylxanthines (such as coffee,
             tea, colas, some 'energy' drinks or chocolate) within 12 hours before surgery.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Gabon</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>United States</country>
  </removed_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2009</study_first_submitted>
  <study_first_submitted_qc>March 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2009</study_first_posted>
  <results_first_submitted>November 20, 2012</results_first_submitted>
  <results_first_submitted_qc>November 20, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 20, 2012</results_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
    <mesh_term>Ventricular Dysfunction, Left</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Cardioplegic Solutions</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acadesine</title>
          <description>Acadesine IV infusion, plus cardioplegia solution with acadesine, and priming solution with acadesine in the heart lung machine during cardiopulmonary bypass (CPB)</description>
        </group>
        <group group_id="P2">
          <title>Placebo (Normal Saline)</title>
          <description>Placebo (normal saline) IV infusion, plus cardioplegia solution with added normal saline, and priming solution with added normal saline in the heart lung machine during CPB</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1536"/>
                <participants group_id="P2" count="1544"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1400"/>
                <participants group_id="P2" count="1413"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="136"/>
                <participants group_id="P2" count="131"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Defined Clinical Event</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="8"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did Not Meet Protocol Eligibility</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Administrative</title>
              <participants_list>
                <participants group_id="P1" count="23"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acadesine</title>
          <description>Acadesine IV infusion, plus cardioplegia solution with acadesine, and priming solution with acadesine in the heart lung machine during cardiopulmonary bypass (CPB)</description>
        </group>
        <group group_id="B2">
          <title>Placebo (Normal Saline)</title>
          <description>Placebo (normal saline) IV infusion, plus cardioplegia solution with added normal saline, and priming solution with added normal saline in the heart lung machine during CPB</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1536"/>
            <count group_id="B2" value="1544"/>
            <count group_id="B3" value="3080"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.2" spread="8.5"/>
                    <measurement group_id="B2" value="66.7" spread="8.7"/>
                    <measurement group_id="B3" value="66.5" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="519"/>
                    <measurement group_id="B2" value="523"/>
                    <measurement group_id="B3" value="1042"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1017"/>
                    <measurement group_id="B2" value="1021"/>
                    <measurement group_id="B3" value="2038"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of All-cause Death, Non-fatal Stroke, and Need for Mechanical Support for Severe Left Ventricular Dysfunction (SLVD) (Intent-to-Treat Population)</title>
        <description>Incidence of all-cause death, non-fatal stroke, or need for mechanical support for SLVD (any component and composite) through post-operative Day 28 during and following CABG and administration of acadesine or placebo. Components defined as follows: All-cause death: Death from any cause, Non-fatal Stoke: occurrence of a stoke that was confirmed and adjudicated by Clinical Endpoints Committee that did not result in death, and Mechanical Support for SLVD: New use of any mechanical support for ≥1 hour for treatment of low cardiac output.</description>
        <time_frame>Up to Post-Operative Day 28</time_frame>
        <population>The Intent-to-Treat Population included all participants randomly assigned to a treatment group and did not have to receive study drug. Each participant contributed to no more than one efficacy endpoint in any composite, i.e., a participant who experienced multiple components of an endpoint composite was counted only once in that composite.</population>
        <group_list>
          <group group_id="O1">
            <title>Acadesine</title>
            <description>Acadesine IV infusion, plus cardioplegia solution with acadesine, and priming solution with acadesine in the heart lung machine during cardiopulmonary bypass (CPB).</description>
          </group>
          <group group_id="O2">
            <title>Placebo</title>
            <description>Placebo (normal saline) IV infusion, plus cardioplegia solution with added normal saline, and priming solution with added normal saline in the heart lung machine during CPB.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of All-cause Death, Non-fatal Stroke, and Need for Mechanical Support for Severe Left Ventricular Dysfunction (SLVD) (Intent-to-Treat Population)</title>
          <description>Incidence of all-cause death, non-fatal stroke, or need for mechanical support for SLVD (any component and composite) through post-operative Day 28 during and following CABG and administration of acadesine or placebo. Components defined as follows: All-cause death: Death from any cause, Non-fatal Stoke: occurrence of a stoke that was confirmed and adjudicated by Clinical Endpoints Committee that did not result in death, and Mechanical Support for SLVD: New use of any mechanical support for ≥1 hour for treatment of low cardiac output.</description>
          <population>The Intent-to-Treat Population included all participants randomly assigned to a treatment group and did not have to receive study drug. Each participant contributed to no more than one efficacy endpoint in any composite, i.e., a participant who experienced multiple components of an endpoint composite was counted only once in that composite.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1536"/>
                <count group_id="O2" value="1544"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Composite of All Events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.9"/>
                    <measurement group_id="O2" value="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>All-Cause Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9"/>
                    <measurement group_id="O2" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Fatal Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                    <measurement group_id="O2" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Need for Mechanical Support for SLVD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                    <measurement group_id="O2" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Cardiovascular Death, Non-fatal Stroke, and Need for Mechanical Support for SLVD (Intent-to-Treat Population)</title>
        <description>Incidence of cardiovascular death, non-fatal stroke, and need for mechanical support for SLVD (any component and composite) through post-operative Day 28 during and following CABG and administration of acadesine or placebo. Components defined as follows: Cardiovascular death: Death due to cardiovascular causes, Non-fatal Stroke: occurrence of a stroke that was confirmed and adjudicated by Clinical Endpoints Committee that did not result in death, and Mechanical Support for SLVD: New use of any mechanical support for ≥1 hour for treatment of low cardiac output.</description>
        <time_frame>Up to Post-Operative Day 28</time_frame>
        <population>The Intent-to-Treat Population included all participants randomly assigned to a treatment group and did not have to receive study drug. Each participant contributed to no more than one efficacy endpoint in any composite, i.e., a participant who experienced multiple components of an endpoint composite was counted only once in that composite.</population>
        <group_list>
          <group group_id="O1">
            <title>Acadesine</title>
            <description>Acadesine IV infusion, plus cardioplegia solution with acadesine, and priming solution with acadesine in the heart lung machine during cardiopulmonary bypass (CPB)</description>
          </group>
          <group group_id="O2">
            <title>Placebo (Normal Saline)</title>
            <description>Placebo (normal saline) IV infusion, plus cardioplegia solution with added normal saline, and priming solution with added normal saline in the heart lung machine during CPB</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Cardiovascular Death, Non-fatal Stroke, and Need for Mechanical Support for SLVD (Intent-to-Treat Population)</title>
          <description>Incidence of cardiovascular death, non-fatal stroke, and need for mechanical support for SLVD (any component and composite) through post-operative Day 28 during and following CABG and administration of acadesine or placebo. Components defined as follows: Cardiovascular death: Death due to cardiovascular causes, Non-fatal Stroke: occurrence of a stroke that was confirmed and adjudicated by Clinical Endpoints Committee that did not result in death, and Mechanical Support for SLVD: New use of any mechanical support for ≥1 hour for treatment of low cardiac output.</description>
          <population>The Intent-to-Treat Population included all participants randomly assigned to a treatment group and did not have to receive study drug. Each participant contributed to no more than one efficacy endpoint in any composite, i.e., a participant who experienced multiple components of an endpoint composite was counted only once in that composite.</population>
          <units>Percentage of Participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1536"/>
                <count group_id="O2" value="1544"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Composite of All Events</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8"/>
                    <measurement group_id="O2" value="4.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Cardiovascular Death</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                    <measurement group_id="O2" value="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Fatal Stroke</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7"/>
                    <measurement group_id="O2" value="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Need for Mechanical Support for SLVD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2"/>
                    <measurement group_id="O2" value="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to Post-Operative Day 28</time_frame>
      <desc>The As-Treated Population was used as the safety population and included all subjects who were assigned randomized treatment and received any amount of study drug (ie, acadesine or placebo).</desc>
      <group_list>
        <group group_id="E1">
          <title>Acadesine</title>
          <description>Acadesine IV infusion, plus cardioplegia solution with acadesine, and priming solution with acadesine in the heart lung machine during cardiopulmonary bypass (CPB)</description>
        </group>
        <group group_id="E2">
          <title>Placebo (Normal Saline)</title>
          <description>Placebo (normal saline) IV infusion, plus cardioplegia solution with added normal saline, and priming solution with added normal saline in the heart lung machine during CPB</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 13.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="327" subjects_at_risk="1442"/>
                <counts group_id="E2" subjects_affected="329" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Coagulopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Heparin-Induced Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Myocardial Infarction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="46" subjects_affected="44" subjects_at_risk="1442"/>
                <counts group_id="E2" events="41" subjects_affected="41" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Atrial Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Atrioventricular Block Complete</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac Arrest</sub_title>
                <counts group_id="E1" events="14" subjects_affected="12" subjects_at_risk="1442"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac Failure</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac Failure Congestive</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="1442"/>
                <counts group_id="E2" events="13" subjects_affected="12" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiac Valve Disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardio-Respiratory Arrest</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiogenic Shock</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cardiopulmonary Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Electromechanical Dissociation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Nodal Rhythm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Right Ventricular Failure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sick Sinus Syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sinus Bradycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Supraventricular Extrasystoles</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Tachyarrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricle Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular Arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular Extrasystoles</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular Fibrillation</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1442"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ventricular Tachycardia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Inappropriate Antidiuretic Hormone Secretion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetic Retinopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal Adhesions</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Abdominal Distension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Abdominal Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Abdominal Pain Upper</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Colitis Ulcerative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Duodenal Ulcer Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Faecaloma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastric Ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastrointestional Necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haematemesis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ileus</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Ileus Paralytic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Impaired Gastric Emptying</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intestinal Ischaemia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Large Intestine Perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lower Gastrointestinal Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Malaena</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Oesophageal Spasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Oesophageal Varices Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Peritonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Small Intestinal Obstruction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Adverse Drug Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Catheter Site Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Device Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Extravasation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gait Disturbance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>General Physical Health Deterioration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Impaired Healing</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Multi-Organ Failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Non-Cardiac Chest Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Organ Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sudden Cardiac Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Systemic Inflammatory Response Syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cholecystitis Acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hepatic Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hydrocholecystis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Anaphylactoid Reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abscess Limb</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bacterial Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bronchopneumonia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cellulitus</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1442"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cholecystitis Infective</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Clostridial Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Drug Related Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Escherichia Bacteraemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Gastroenteritis Viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haematoma Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incision Site Infection</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1442"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mediastinal Abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mediastinitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pharyngitis Streptococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="1442"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative Wound Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pyelonepritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pyothorax</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory Tract Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1442"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Septic Shock</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Staphylococcal Infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Staphylococcal Mediastinitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Wound Infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1442"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Wound Infection Pseudomonas</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Wound Infection Staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Collapse of Lung</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Drug Toxicity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Femur Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Graft Haemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incision Site Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Operative Haemorrhage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Post Procedural Haemorrhage</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="1442"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative Ileus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative Renal Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative Respiratory Distress</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postoperative Thoracic Procedure Complication</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Postpericardiotomy Syndrome</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal Injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Shunt Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Traumatic Lung Injury</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vascular Graft Occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vascular Graft Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vasoplegia Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Weaning Failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Wound Complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Wound Dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Cardiac Output Decreased</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Electrocardiogram Change</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>International Normalised Ratio Increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulse Absent</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>White Blood Cell Count Increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Dehydration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diabetes Mellitus Inadequate Control</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Electrolyte Imbalance</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Fluid Overload</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metabolic Acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metabolic Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Fracture Delayed Union</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Musculoskeletal Chest Pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pain in Extremity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Renal Cancer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Squamous Cell Carcinoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Anoxic Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Carpal Tunnel Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cerebrovascular Incident</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Convulsion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Depressed Level of Consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypoxic Encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Metabolic Encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Paresis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Presynope</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Affective Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Disorientation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hallucination, Visual</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mental Status Changes</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Suicidal Ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Transient Psychosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Prerenal Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haematuria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal Failure</sub_title>
                <counts group_id="E1" events="21" subjects_affected="20" subjects_at_risk="1442"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal Failure Acute</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="1442"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Renal Tubular Necrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urinary Retention</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Acute Repiratory Failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Asphyxia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Bronchospasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Chronic Obstructive Pulmonary disease</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Dyspnoea</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haemothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hydropneumothorax</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lung Disorder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="31" subjects_affected="28" subjects_at_risk="1442"/>
                <counts group_id="E2" events="27" subjects_affected="26" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pleural Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pleuritic Pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1442"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Embolism</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="1442"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Fibrosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Haematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Haemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory Alkalosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory Arrest</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory Distress</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <counts group_id="E1" events="34" subjects_affected="33" subjects_at_risk="1442"/>
                <counts group_id="E2" events="25" subjects_affected="23" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Tracheal Stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Diabetic Ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Linear IGA Disease</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Subcutaneous Emphysema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Aortic Bypass</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Incisional Drainage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Mechanical Ventilation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Thoracic Cavity Drainage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Air Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Aortic Rupture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Arterial Thrombosis Limb</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Arteriovenous Fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1442"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Exsanguination</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haemodynamic Instability</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Haemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypertensive Crisis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="16" subjects_affected="14" subjects_at_risk="1442"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Jugular Vein Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Labile Blood Pressure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Lymphatic Fistula</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Orthostatic Hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Peripheral Arterial Occlusive Disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Peripheral Embolism</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Peripheral Ischaemia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1442"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Peripheral Vascular Disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Shock Haemorrhagic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Thrombophlebitis Superficial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Venous Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>White Clot Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="1442"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 13.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1154" subjects_at_risk="1442"/>
                <counts group_id="E2" subjects_affected="1189" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaemia</sub_title>
                <counts group_id="E1" events="388" subjects_affected="384" subjects_at_risk="1442"/>
                <counts group_id="E2" events="387" subjects_affected="383" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Leukocytosis</sub_title>
                <counts group_id="E1" events="117" subjects_affected="114" subjects_at_risk="1442"/>
                <counts group_id="E2" events="95" subjects_affected="95" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="123" subjects_affected="119" subjects_at_risk="1442"/>
                <counts group_id="E2" events="129" subjects_affected="129" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" events="303" subjects_affected="290" subjects_at_risk="1442"/>
                <counts group_id="E2" events="346" subjects_affected="328" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Sinus Tachycardia</sub_title>
                <counts group_id="E1" events="82" subjects_affected="81" subjects_at_risk="1442"/>
                <counts group_id="E2" events="67" subjects_affected="67" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="209" subjects_affected="207" subjects_at_risk="1442"/>
                <counts group_id="E2" events="245" subjects_affected="244" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="362" subjects_affected="354" subjects_at_risk="1442"/>
                <counts group_id="E2" events="373" subjects_affected="365" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="81" subjects_affected="80" subjects_at_risk="1442"/>
                <counts group_id="E2" events="86" subjects_affected="86" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Generalized Oedema</sub_title>
                <counts group_id="E1" events="87" subjects_affected="87" subjects_at_risk="1442"/>
                <counts group_id="E2" events="85" subjects_affected="85" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Oedema Peripheral</sub_title>
                <counts group_id="E1" events="112" subjects_affected="108" subjects_at_risk="1442"/>
                <counts group_id="E2" events="134" subjects_affected="124" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="100" subjects_affected="100" subjects_at_risk="1442"/>
                <counts group_id="E2" events="123" subjects_affected="119" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="122" subjects_affected="117" subjects_at_risk="1442"/>
                <counts group_id="E2" events="105" subjects_affected="105" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Incision Site Pain</sub_title>
                <counts group_id="E1" events="221" subjects_affected="218" subjects_at_risk="1442"/>
                <counts group_id="E2" events="211" subjects_affected="205" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Procedural Pain</sub_title>
                <counts group_id="E1" events="572" subjects_affected="560" subjects_at_risk="1442"/>
                <counts group_id="E2" events="543" subjects_affected="525" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperglycaemia</sub_title>
                <counts group_id="E1" events="181" subjects_affected="180" subjects_at_risk="1442"/>
                <counts group_id="E2" events="165" subjects_affected="165" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypocalcaemia</sub_title>
                <counts group_id="E1" events="86" subjects_affected="85" subjects_at_risk="1442"/>
                <counts group_id="E2" events="74" subjects_affected="74" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypokalaemia</sub_title>
                <counts group_id="E1" events="143" subjects_affected="139" subjects_at_risk="1442"/>
                <counts group_id="E2" events="127" subjects_affected="126" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" events="75" subjects_affected="75" subjects_at_risk="1442"/>
                <counts group_id="E2" events="89" subjects_affected="88" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" events="89" subjects_affected="89" subjects_at_risk="1442"/>
                <counts group_id="E2" events="87" subjects_affected="87" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Atelectasis</sub_title>
                <counts group_id="E1" events="265" subjects_affected="257" subjects_at_risk="1442"/>
                <counts group_id="E2" events="252" subjects_affected="241" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pleural Effusion</sub_title>
                <counts group_id="E1" events="340" subjects_affected="323" subjects_at_risk="1442"/>
                <counts group_id="E2" events="352" subjects_affected="336" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Pulmonary Oedema</sub_title>
                <counts group_id="E1" events="59" subjects_affected="59" subjects_at_risk="1442"/>
                <counts group_id="E2" events="76" subjects_affected="76" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="76" subjects_affected="74" subjects_at_risk="1442"/>
                <counts group_id="E2" events="76" subjects_affected="74" subjects_at_risk="1457"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="286" subjects_affected="280" subjects_at_risk="1442"/>
                <counts group_id="E2" events="283" subjects_affected="280" subjects_at_risk="1457"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The investigator agrees not to publish or publicly present any interim results
of the study without the prior written consent of the sponsor. The investigator further agrees to provide to the sponsor 45 days prior to submission for publication or presentation, review copies of abstracts or manuscripts for publication (including, without limitation, slides and texts of oral or other public presentations and texts of any transmission through any electronic media that report any study results).</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

